{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:55:10Z","timestamp":1790618110352,"version":"4.1.0"},"reference-count":9,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/100007776","name":"Deanship of Academic Research, University of Jordan","doi-asserted-by":"publisher","award":["116-2015\/2016"],"award-info":[{"award-number":["116-2015\/2016"]}],"id":[{"id":"10.13039\/100007776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2020,6,11]]},"abstract":"<jats:sec>\n<jats:title>Background and Objective:<\/jats:title>\n<jats:p>Inflammatory bowel disease (IBD) is a set of chronic inflammatory gastrointestinal\ndisorders, which include ulcerative colitis (UC) and Crohn\u2019s disease (CD) that affects many patients\nworldwide with a peak incidence in early adult life. The immunosuppressant drug Azathioprine (AZA) represents\none of the most useful drugs in the management of IBD. It is metabolized by many enzymes like AOX1, and XDH\nenzymes, the variation in the metabolism of AZA may contribute to inter-individual variation in response to this\ntreatment. This study aims to find out if there is an association between certain AOX1 and XDH polymorphisms and\nAZA response in Jordanian IBD patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>One hundred IBD patients aged between (17-72) years and taking AZA were enrolled and genotyped for\nAOX13404G, XDH1936C and XDH2107C polymorphisms using DNA Sequencing (Sanger) method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results and Conclusion:<\/jats:title>\n<jats:p>This study revealed that 16% of our patients were non-responders to AZA; they needed an\nalternative therapy (biological agent) or steroids along with AZA. There was no statistically significant association\n(p-value&gt;0.05) between the AOX1 3404G, XDH 1936C and XDH 2107C polymorphisms and the response to AZA\namong Jordanian IBD patients. Finally, the study showed an association between the age of the patient and the response\nto AZA (p-value=0.013).<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389200221666200413125011","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T18:53:31Z","timestamp":1586804011000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["AOX1 and XDH Enzymes Genotyping and its Effect on Clinical Response to Azathioprine in Inflammatory Bowel Disease Patients Among Jordanian Population"],"prefix":"10.2174","volume":"21","author":[{"given":"Sereen","family":"Mahasneh","sequence":"first","affiliation":[{"name":"Department of Pharmacology, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Sharab","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al Shhab","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rashid","sequence":"additional","affiliation":[{"name":"Internal Medicine, Jordan University Hospital, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-3908","authenticated-orcid":true,"given":"Malek","family":"Zihlif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","volume":"347","year":"1996","unstructured":"Bouhnik, Y.; Scemama, G.; Ta\u00ef, R.; Matuchansky, C.; Rambaud, J. C.; L\u00e9mann, M.; Mary, J. Y. Long-term follow-up of patients with Crohn\u2019s disease treated with azathioprine or 6-mercaptopurine. Lancet 1996,347(8996),215-219","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","volume":"88","author":"George J.N.","year":"1996","unstructured":"George J.N.; Woolf S.H.; Raskob G.E.; Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996,88(1),3-40","journal-title":"Blood"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","volume":"24","author":"Derijks L.J.J.","year":"2006","unstructured":"Derijks L.J.J.; Gilissen L.P.L.; Hooymans P.M.; Hommes D.W.; Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther 2006,24(5),715-729","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2036.2009.04057.x","volume":"30","author":"Smith M.A.","year":"2009","unstructured":"Smith M.A.; Marinaki A.M.; Arenas M.; Shobowale-Bakre M.; Lewis C.M.; Ansari A.; Duley J.; Sanderson J.D.; Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease. Aliment Pharmacol Ther 2009,30(4),375-384","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.2174\/138161210794079155","volume":"16","author":"Sohrabpour A.A.","year":"2010","unstructured":"Sohrabpour A.A.; Malekzadeh R.; Keshavarzian A.; Current therapeutic approaches in inflammatory bowel disease. Curr Pharm Des 2010,16(33),3668-3683","journal-title":"Curr Pharm Des"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/S0016-5085(00)70007-2","volume":"118","author":"Sands B.E.","year":"2000","unstructured":"Sands B.E.; Therapy of inflammatory bowel disease. Gastroenterology 2000,118(2)(Suppl. 1),S68-S82","journal-title":"Gastroenterology"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"12519","DOI":"10.3748\/wjg.v21.i44.12519","volume":"21","author":"Quetglas E.G.","year":"2015","unstructured":"Quetglas E.G.; Mujagic Z.; Wigge S.; Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J Gastroenterol 2015,21(44),12519","journal-title":"World J Gastroenterol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1124\/dmd.111.043828","volume":"40","author":"Hartmann T.","year":"2012","unstructured":"Hartmann T.; Terao M.; Garattini E.; Teutloff C.; Alfaro J.F.; Jones J.P.; Leimk\u00fchler S.; The impact of single nucleotide polymorphisms on human aldehyde oxidase. Drug Metab Dispos 2012,40(5),856-864","journal-title":"Drug Metab Dispos"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/FPC.0b013e3282f55e2e","volume":"18","author":"Kudo M.","year":"2008","unstructured":"Kudo M.; Moteki T.; Sasaki T.; Functional characterization of human xanthine oxidase allelic variants. Pharmacogenet Genomics 2008,18(3),243-251","journal-title":"Pharmacogenet Genomics"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/180852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T07:24:16Z","timestamp":1596353056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/180852\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389200221666200413125011","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}